Company news

Nanoform Finland Oyj (OMXHEX:NANOFH) news

Nanoform Finland Oyj news releases on 6ix. Latest, Aug 20, 2026: Nanoform Finland Oyj : Interim Report for January-June 2026 (Report)

View Nanoform Finland Oyj →

Press releases & updates

Nanoform Finland Oyj : Interim Report for January-June 2026 (Report)

August 20, 2026

Nanoform Finland Oyj : Invitation to Nanoform's Q2 2026 Report Presentation

August 6, 2026

The Board of Directors of Nanoform Finland Plc decided on issue of stock options to key individuals

May 29, 2026

Nanoform Q1 2026 report - Record first quarter revenue, income and gross margin, first exclusivity deal signed around our Biologics technology

May 19, 2026

Inside information: Nanoform Signs First Exclusivity Agreement for Ultra-High Concentration Subcutaneous Delivery

May 12, 2026

Resolutions of the Constitutive Meeting of the Board of Directors of Nanoform Finland Plc

April 21, 2026

Resolutions of Nanoform Finland Plc's Annual General Meeting on April 21, 2026

April 21, 2026

Nanoform Finland Plc – Manager’s Transactions – Peter Hänninen

April 2, 2026

Nanoform Finland Plc – Manager’s Transactions – Albert Hæggström

April 2, 2026

Inside information: Feedback from European Scientific Advice Meeting with Reference Member State Will Delay Submission of European Marketing Authorization Application Planned Initially for May 2026

March 30, 2026

Notice to the Annual General Meeting of NANOFORM FINLAND Plc

March 19, 2026

Nanoform Finland Plc – Manager’s Transactions – David Rowe

March 2, 2026

Nanoform Finland Plc – Manager’s Transactions – Christian Jones

March 2, 2026

Nanoform Finland Plc – Manager’s Transactions – Edward Hæggström

March 2, 2026

Nanoform Finland Plc – Manager’s Transactions – Antonio Da Silva

March 2, 2026

The Board of Directors of Nanoform Finland Plc decided on issue of stock options under an option program open to all employees

March 2, 2026

Nanoform Q4 & FY2025 report - Next: the submission of a marketing authorization application for Nanoenzalutamide in Europe

February 26, 2026

Nanoform Finland Plc’s change negotiations have ended

February 5, 2026